Nebulized gentamicin in children with cystic fibrosis: Enhancing antibiotic lung deposition by increasing flow rate and fill volume

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 10, Issue 4, 1997, Pages 331-340

  Mallol, Javier ^a,b   Robertson, Colin F ^a   Cook, David ^a   Kaymakci, Bahitiyar ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

Author keywords

Antibiotic aerosol; Children with cystic fibrosis; Gentamicin lung deposition; Particle size

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; PENTETATE TECHNETIUM TC 99M;

ADOLESCENT; ADULT; AEROSOL; ANTIBIOTIC THERAPY; ARTICLE; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; CYSTIC FIBROSIS; DRUG DELIVERY SYSTEM; FEMALE; FLOW RATE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG DISEASE; MALE; NEBULIZER; PARTICLE SIZE; RANDOMIZED CONTROLLED TRIAL;

EID: 0031441435     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.1997.10.331     Document Type: Article

References (16)

1. Hodson, M.E., A.R.L. Penketh, and J.C. Batten. 1981. Aerosol carbenicillin and gentamicin in adults with cystic fibrosis. Lancet 2:1137-1139.
2. Kun, P., L.I. Landau, and P.D. Phelan. 1984. Nebulized gentamicin in children and adolescents with cystic fibrosis. Aust Paediatr J. 20:43-45.
3. Clay, M.M., D. Pavia, S.P. Newman, T. Lennard-Jones, and S.W. Clarke. 1983. Assessment of jet nebulizers for lung aerosol therapy. Lancet 2:592-594.
4. Clay, M.M., D. Pavia, S.P. Newman, and S.W. Clarke. 1983. Factors influencing the size distribution of aerosols from jet nebulizers. Thorax 38:755-759.
5. Mallol, J. 1993. Particle size distribution for jet nebulizers commonly employed in the pediatric clinical setting. J. Aerosol. Med. 6:213-319.
6. Mallol, J., F. Cortes, L. Barrueto, and J. Zuniga. 1994. Variability in the function of Hudson jet nebulizers. Rev. Chil. Enf. Respir. 10:25-33.
7. Newman, S.P., P.G.D. Pellow, and S.W. Clarke. 1986. Droplet size distributions of nebulized aerosols for inhalation therapy. Clin. Phys. Physiol. Meas. 7:139-146.
8. Newman, S., G. Woodman, and S.W. Clarke. 1988. Deposition of carbenicillin aerosols in cystic fibrosis: Effects of nebulizer system and breathing pattern. Thorax. 43:318-322.
9. Ilowite, J.S., J.D. Gorvoy, and G.C. Smaldone. 1987. Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am. Rev. Respir. Dis. 136:1445-1449.
10. Mukhopadhyay, S., G.E. Staddon, C. Eastman, M.R.D. Palmer, and F. Carswell. 1994. The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis. Respir. Med. 88:203-211.
11. Dashe, C.K., R.A. Ponto, C.M. Ganapes, C.W. Drage, and R.S. Kronenberg. 1974. The distribution of nebulized isoproterenol and its effect on regional ventilation and perfusion. Am. Rev. Respir. Dis. 110:293-300.
12. Smaldone, G.C., J. Fuhrer, R.T. Steigbigel, and M. McPeck. 1991. Factors determining pulmonary deposition of aerosolized pentamidine in patients with human immunodeficiency virus infection. Am. Rev. Respir. Dis. 143:727-737.
13. Smith, D., D. Erskine, J. Steele, D. Hills, and B. Gazzard. 1992. Comparison of nebuliser efficiency for aerosolizing pentamidine. J. Pharm. Pharmacol. 244:7-9.
14. Sterk, Pj., A. Plomp, J.F. Van De Vate, and P.H. Quanjer. 1984. Physical properties of aerosols produced by several jet and ultrasonic nebulizers. Bull. Eur. Physiopathol. Respir. 20:65-72.
15. Ferron, G.A. 1994. Aerosol properties and lung deposition. Eur. Respir. J. 7:1392-1394.
16. Laube, B.L., D.Y. Chang, A. Nussbaum, and B.J. Rosenstein. 1992. Radioaerosol assessment of lung improvement in cystic fibrosis patients treated for acute pulmonary exacerbations. Chest 101:1302-1308.